CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teijin Limited v. Unimark Remedies Ltd.

1:14-cv-01370

Overview

Case Number 1:14-cv-01370
Filing Date 2014-11-04
Status Terminated
Termination Date 2016-01-05
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand None

Parties

Defendant

Unimark Remedies Ltd. Operating Company

Represented By

4 Attorneys Listed

Jeffrey S. Ward

Email: jward@nge.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Counter Defendant

Teijin Pharma Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Teijin Limited NPE (University / Research)

Represented By

7 Attorneys Listed

Melanie R. Rupert

Email: melanierupert@paulhastings.com

Jason T. Christiansen

Email: jasonchristiansen@paulhastings.com

James T. Evans

Email: jamesevans@paulhastings.com

David M. Conca

Email: davidconca@paulhastings.com

Bruce M. Wexler

Email: brucewexler@paulhastings.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Takeda Pharmaceuticals USA Inc. Operating Company

Represented By

5 Attorneys Listed

Scott B. Howard

Email: sbhoward@pbwt.com

Zhiqiang Liu

Email: zliu@pbwt.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Willam F Cavanaugh , Jr.

Email: wfcavanaugh@pbwt.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 8 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (8 found):
U.S. Courts: 8
U.S. District Court 2015-06-04
1:15-cv-00454

Teijin Limited v. Macleods Pharmaceuticals Ltd.

Asserted Patent
Status: DED
U.S. District Court 2014-07-01
1:14-cv-00854

Teijin Limited v. Prinston Pharmaceutical Inc.

U.S. Family Sibling (["US6225474", "US8372872"])
Status: DED
U.S. District Court 2014-02-12
1:14-cv-00189

Teijin Limited v. Roxane Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-02-07
1:14-cv-00166

Teijin Limited v. Hetero USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-12-23
1:13-cv-02086

Teijin Limited v. Zydus Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-11-19
1:13-cv-01939

Teijin Limited v. Alembic Pharmaceuticals Limited

Asserted Patent
Status: DED
U.S. District Court 2013-11-06
1:13-cv-01851

Teijin Limited v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-10-30
1:13-cv-01780

Teijin Limited v. Dr. Reddy's Laboratories Ltd.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7361676
Solid preparation containing single crystal form
Filed: 2003-03-28
Issued: 2008-04-22
Expired (Term Ended) +346d PTA
Expires: 2024-03-08
US8372872
Methods for concomitant treatment of theophylline and febuxostat
Filed: 2011-11-14
Issued: 2013-02-12
Active (5.0 yrs remaining)
Expires: 2031-11-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+346 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Claim Construction / Markman Filing 1 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re 26 STIPULATION TO EXTEND TIME for various deadlines to dates as outlined in stipulation filed by Takeda Pharmaceuticals USA Inc., Teijin Pharma L...
Entry #— • 2015-09-10
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for various deadlines to dates as outlined in stipulation - filed by Takeda Pharmaceuticals USA Inc., Teijin Limited, Teijin Pharma L...
Entry #26 • 2015-09-08 Document →
Claim Construction / Markman Filing Pending
SO ORDERED, re 14 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. ( Joinder of Parties due by 10/9/2015., Amended Plea...
Entry #— • 2014-12-22

Docket Entries

(107 total)
Pleading / Complaint

COMPLAINT - filed against Unimark Remedies Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1620220.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(rwc) (Entered: 11/04/2014)

Entry #1 • 2014-11-04
1
Pleading / Complaint

COMPLAINT - filed against Unimark Remedies Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1620220.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(rwc) (Entered: 11/04/2014)

Entry #1 • 2014-11-04
2
Pleading / Complaint

COMPLAINT - filed against Unimark Remedies Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1620220.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(rwc) (Entered: 11/04/2014)

Entry #1 • 2014-11-04
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 11/04/2014)

Entry #2 • 2014-11-04
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/24/14. Date of Expiration of Patent: 3/8/24.Thirty Month Stay Deadline: 3/24/2017. (rwc) (Entered: 11/04/2014)

Entry #3 • 2014-11-04
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc